Endocrine Abstracts

Introduction: In the management of patients with differentiated thyroid carcinoma, serum thyroglobulin levels are often well correlated with whole-body radioiodine scanning (WBS) results. However, occasionally, a mismatched result – increased thyroglobulin with negative WBS – is observed. Radioiodine therapy has been suggested as a therapeutic choice with controversial results.Method: We studied 32 differentiated thyroid carcinoma patients with...

At the present time, the most widely accepted tool for follow-up management of differentiated thyroid cancer (DTC) patients consists of serum thyroglobulin (Tg) measurement. It is not uncommon to measure the serum Tg level while the patient taking thyroid hormones (on-treatment Tg measurement). The purpose of the study was to evaluate the accuracy of on-treatment measurement of serum Tg in detecting remnant/recurrent or metastatic disease in high risk DTC patients. Patients an...

Introduction: In the management of patients with differentiated thyroid carcinoma (DTC), serum thyroglobulin (Tg) levels are often well correlated with whole-body radio-iodine scanning (WBS) results. However, occasionally a mismatched result, increased Tg with negative WBS, is encountered. High doses of radio-iodine (RAI) have been suggested as a therapeutic choice with controversial results. Our aim was to evaluate the therapeutic benefit of this approach.<p class="abstex...